Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.3B
| $18.1M | 0.02% |
178,400
+113,100
| +173% | +$11.4M |
2017 Q4
10 quarters
|
|
|
PDM
877
Piedmont Realty Trust
PDM
$1.13B
| $18.1M | 0.02% |
1,087,100
-1,292,800
| -54% | -$21.6M |
2014 Q3
23 quarters
|
|
878
Extreme Networks
EXTR
$3.2B
| $18.1M | 0.02% |
4,159,446
+599,200
| +17% | +$2.11M |
2013 Q2
28 quarters
|
|
|
OLP
879
One Liberty Properties
OLP
$481M
| $18M | 0.02% |
1,022,936
-85,289
| -8% | -$1.35M |
2013 Q2
28 quarters
|
|
880
EPAM Systems
EPAM
$5.84B
| $18M | 0.02% |
+71,400
| New | +$15.7M |
2020 Q2
0 quarters
|
|
881
FormFactor
FORM
$10.9B
| $18M | 0.02% |
612,569
-591,400
| -49% | -$14.6M |
2013 Q2
28 quarters
|
|
882
Arthur J. Gallagher & Co
AJG
$59.7B
| $17.9M | 0.02% |
184,100
+88,700
| +93% | +$7.85M |
2019 Q1
5 quarters
|
|
883
Werner Enterprises
WERN
$1.96B
| $17.9M | 0.02% |
411,263
+348,170
| +552% | +$14.3M |
2019 Q2
4 quarters
|
|
884
Endava
DAVA
$106M
| $17.8M | 0.02% |
369,075
+33,500
| +10% | +$1.49M |
2019 Q2
4 quarters
|
|
885
Open Text
OTEX
$5.74B
| $17.8M | 0.02% |
418,400
-475,200
| -53% | -$18.8M |
2018 Q3
7 quarters
|
|
886
National Presto Industries
NPK
$1.08B
| $17.8M | 0.02% |
203,200
+27,500
| +16% | +$2.34M |
2014 Q4
22 quarters
|
|
|
PRSP
887
DELISTED
Perspecta Inc. Common Stock
PRSP
| $17.7M | 0.02% |
762,969
+610,669
| +401% | +$13.3M |
2019 Q2
4 quarters
|
|
888
Liberty Media Corporation Series A Common Stock
FWONA
$21.7B
| $17.7M | 0.02% |
633,613
-67,394
| -10% | -$1.88M |
2014 Q4
22 quarters
|
|
889
CRA International
CRAI
$1.11B
| $17.7M | 0.02% |
447,575
-18,699
| -4% | -$710K |
2014 Q1
25 quarters
|
|
|
ANAT
890
DELISTED
American National Group, Inc. Common Stock
ANAT
| $17.7M | 0.02% |
245,201
+50,600
| +26% | +$3.78M |
2013 Q2
28 quarters
|
|
891
Park Aerospace
PKE
$574M
| $17.7M | 0.02% |
1,585,201
+128,304
| +9% | +$1.59M |
2013 Q2
28 quarters
|
|
|
TGI
892
DELISTED
Triumph Group
TGI
| $17.6M | 0.02% |
1,952,400
+688,548
| +54% | +$5.09M |
2019 Q1
5 quarters
|
|
893
Encompass Health
EHC
$12.2B
| $17.6M | 0.02% |
356,234
+118,787
| +50% | +$6.41M |
2020 Q1
1 quarter
|
|
894
Clean Energy Fuels
CLNE
$324M
| $17.5M | 0.02% |
7,901,332
-1,140,800
| -13% | -$2.3M |
2016 Q2
16 quarters
|
|
895
TransAlta
TAC
$4.15B
| $17.5M | 0.02% |
2,958,141
-544,100
| -16% | -$3.13M |
2014 Q2
24 quarters
|
|
896
W.R. Berkley
WRB
$26.7B
| $17.5M | 0.02% |
688,725
-370,575
| -35% | -$9.09M |
2019 Q4
2 quarters
|
|
897
QCR Holdings
QCRH
$1.59B
| $17.5M | 0.02% |
562,200
-31,000
| -5% | -$893K |
2014 Q1
25 quarters
|
|
|
MRSH
898
Marsh
MRSH
$83.9B
| $17.5M | 0.02% |
+163,000
| New | +$16.5M |
2020 Q2
0 quarters
|
|
899
Ezcorp Inc
EZPW
$1.96B
| $17.5M | 0.02% |
2,777,741
-190,487
| -6% | -$1.03M |
2015 Q2
20 quarters
|
|
|
DSPG
900
DELISTED
DSP Group Inc
DSPG
| $17.5M | 0.02% |
1,102,000
+105,800
| +11% | +$1.73M |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.